Azithromycin Attenuates Bleomycin-Induced Pulmonary Fibrosis Partly by Inhibiting the Expression of LOX and LOXL-2

• Κύριοι συγγραφείς: Xiang Tong (Συγγραφέας), Shijie Zhang (Συγγραφέας), Dongguang Wang (Συγγραφέας), Li Zhang (Συγγραφέας), Jizheng Huang (Συγγραφέας), Tianli Zhang (Συγγραφέας), Hong Fan (Συγγραφέας)
• Μορφή: Βιβλίο
• Έκδοση: Frontiers Media S.A., 2021-11-01T00:00:00Z.
• Θέματα: article
• Διαθέσιμο Online: Connect to this object online.

Pulmonary fibrosis (PF) is a chronic and progressive process of tissue repair. Azithromycin (AZM) may be beneficial for the treatment of PF because AZM has anti-inflammatory and immune regulatory roles and inhibits remodeling, but the mechanism is not entirely clear. In this study, we established a...